🔗 Share this article

Treasury head Reeves has revealed she is planning "focused measures to address household expense pressures" in the upcoming Budget.

In comments to the BBC, she noted that curbing inflation is a collective task of both the administration and the Bank of England.

The UK's price growth is projected to be the highest among the G7 advanced economies this calendar year and the following year.

Potential Energy Cost Interventions

Sources suggest the government could intervene to lower utility costs, for example by cutting the current 5% rate of VAT applied on energy supplies.

An additional option is to cut some of the government charges currently added to household expenses.

Budgetary Limitations and Analyst Expectations

The government will obtain the latest report from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much scope there is for such actions.

The expectation from most experts is that Reeves will have to announce higher taxes or expenditure reductions in order to meet her voluntary fiscal targets.

Earlier on the same day, calculations suggested there was a £22bn deficit for the Treasury chief to resolve, which is at the more modest range of forecasts.

"There's a collective task between the Bank of England and the government to bear down further on some of the causes of inflation," Reeves told reporters in Washington, at the conferences of the International Monetary Fund and global financial institution.

Tax Commitments and International Concerns

While much of the attention has been on likely tax increases, the Treasury chief said the latest figures from the fiscal watchdog had not altered her vow to manifesto promises not to increase tax levels on income tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with rising geopolitical and trade concerns for the fiscal revenue measures, probably to be directed on those "wealthiest."

Global Trade Tensions

Referring to worries about the United Kingdom's economic relations with the Asian nation she said: "Our national security always take priority."

Last week's announcement by China to strengthen trade restrictions on rare earths and other materials that are key for high-technology manufacturing led US President Donald Trump to threaten an further 100% tariff on imports from the Asian country, increasing the risk of an all-out commercial conflict between the two global powers.

The US Treasury Secretary labeled China's move "commercial pressure" and "a international production power grab."

Questioned on considering the US offer to join its battle with the Asian nation, the Chancellor said she was "very concerned" by Chinese actions and called on the Beijing authorities "not to put up barriers and limit trade."

She said the action was "harmful for the international commerce and causes further obstacles."

"It is my opinion there are areas where we need to challenge Chinese policies, but there are also important chances to sell into Chinese markets, including financial services and other areas of the economic system. We've got to get that equilibrium right."

The Treasury chief also affirmed she was collaborating with international partners "regarding our own critical minerals strategy, so that we are more independent."

NHS Medicine Costs and Funding

The Chancellor also acknowledged that the price the National Health Service spends on pharmaceuticals could rise as a result of ongoing talks with the US government and its pharmaceutical firms, in return for reduced taxes and capital.

Some of the biggest global drug companies have said in recent statements that they are either pausing or scrapping investments in the United Kingdom, with several attributing the modest returns they are getting.

Recently, the Science Minister said the price the health service pays for drugs would need to increase to prevent companies and drug research funding leaving the United Kingdom.

Reeves told media: "It has been observed due to the payment system, that medical research, recent pharmaceuticals have not been offered in the United Kingdom in the extent that they are in other EU nations."

"Our aim is to guarantee that patients receiving care from the National Health Service are can receive the finest life-saving treatments in the globe. And so we are reviewing these issues, and... looking to obtain additional capital into Britain."